Burden of Skin Diseases

Bickers DR, et al. The burden of skin diseases, 2004: a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol . 2006;55:490–500.

Dermatologic Disease and Cardiovascular Disease, with a Focus on Psoriasis

Azfar RS, Gelfand JM.  Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol. 2008 Jul;20(4):416-22.

Balci, D., et al., Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol, 2008.

Brauchli, Y.B., S.S. Jick, and C.R. Meier, Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol, 2008. http://jama.ama-

Christophers E. Comorbidities in psoriasis. Clin Dermatol. 2007 Nov-Dec;25(6):529-34.

Cohen AD, et al. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology. 2008;216(2):152-5. Epub 2008 Jan 23.

Gelfand, J.M., Long-term treatment for severe psoriasis: we're halfway there, with a long way to go. Arch Dermatol, 2007. 143(9): p. 1191-3.

Gelfand, J.M., et al., The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol, 2007. 143(12): p. 1493-9.

Gelfand JM, et al. Risk of Myocardial Infarction in Patients with Psoriasis. JAMA. 2006 Oct 11; 296(14):1735-41.

Gladman DD, et al. Cardiovascular morbidity in psoriatic arthritis (PsA). Ann Rheum Dis. 2008 Aug 12. [Epub ahead of print].

Gottlieb AB, et al. Psoriasis comorbidities. J Dermatolog Treat. 2008;19(1):5-21. 

Gulliver W. Long-term prognosis in patients with psoriasis. Br J Dermatol. 2008 Aug;159 Suppl 2:2-9.

Kaye JA, et al. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol. 2008 Jul 1. [Epub ahead of print]

Kimball AB, et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol. 2008 Jun;58(6):1031-42. Epub 2008 Mar 4.

Ludwig, R.J., et al., Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol, 2007. 156(2): p. 271-6.

Mrowietz U, et al. The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Arch Dermatol Res. 2006 Dec;298(7):309-19. Epub 2006 Oct 5.

Neimann AL, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006 Nov;55(5):829-35. Epub 2006 Sep 25.

Spah F. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol. 2008 Aug;159 Suppl 2:10-7.

Wakkee M, et al. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis. 2007 Jan;190(1):1-9. Epub 2006 Aug 30.

Wu Y, et al. Psoriasis: cardiovascular risk factors and other disease comorbidities. J Drugs Dermatol. 2008 Apr;7(4):373-7.

Dermatologic Disease and Psychiatric Disease, with a Focus on Acne

Aktan S, et al. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol. 2000 May;39(5):354-7.  

Azoulay L, et al. Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry. 2008 Apr;69(4):526-32.

Barankin B, DeKoven J. Psychosocial effect of common skin diseases. Can Fam Physician. 2002 Apr;48:712-6.  

Bowe WP, et al. Body dysmorphic disorder symptoms among patients with acne vulgaris. J Am Acad Dermatol. 2007 Aug;57(2):222-30. Epub 2007 May 10.

Evers AW, et al. Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis. Br J Dermatol. 2005 Jun;152(6):1275-81.

Evers AW, et al. The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument. Br J Dermatol. 2008 Jan;158(1):101-8. Epub 2007 Nov 10.

Fried RG, et al. Depression and skin disease. Dermatol Clin. 2005 Oct;23(4):657-64.  

Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998 Nov;139(5):846-50.

Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol. 2003;4(12):833-42.

Gupta MA, et al. Psychiatric evaluation of the dermatology patient. Dermatol Clin. 2005 Oct;23(4):591-9.  

Jafferany M. Psychodermatology: a guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiatry. 2007;9(3):203-13.  

Magin P, et al. A cross-sectional study of psychological morbidity in patients with acne, psoriasis and atopic dermatitis in specialist dermatology and general practices. J Eur Acad Dermatol Venereol. 2008 Jun 26. [Epub ahead of print]

Mostaghimi L. Prevalence of mood and sleep problems in chronic skin diseases: a pilot study. Cutis. 2008 May;81(5):398-402.

Owoeye OA, et al. An assessment of emotional pain among subjects with chronic dermatological problems in Lagos, Nigeria. Int J Psychiatry Med. 2007;37(2):129-38.

Pearl A, et al. The impact of acne: a study of adolescents' attitudes, perception and knowledge. N Z Med J. 1998 Jul 24;111(1070):269-71.

Picardi A, et al. Prevalence and correlates of suicidal ideation among patients with skin disease. J Am Acad Dermatol. 2006 Mar;54(3):420-6. Epub 2006 Jan 18.

Quandt SA, et al. The association of dermatologist-diagnosed and self-reported skin diseases with skin-related quality of life in Latino migrant farmworkers. Int J Dermatol. 2008 Mar;47(3):236-41.

Smithard A, et al. Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study. Br J Dermatol. 2001 Aug;145(2):274-9.

Urpe M, et al. Psychosomatic factors in dermatology. Dermatol Clin. 2005 Oct;23(4):601-8.  

Uzun O, et al. Body dysmorphic disorder in patients with acne. Compr Psychiatry. 2003 Sep-Oct;44(5):415-9.

Vargas Laguna E, et al. Influence of anxiety in diverse cutaneous diseases [Article in Spanish]. Actas Dermosifiliogr. 2006 Dec;97(10):637-43.

Yazici K, et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol. 2004 Jul;18(4):435-9.

Dermatologic Effects of Treating Extracutaneous Disease, with a Focus on Oncology

Agha R, et al. Dermatologic challenges in cancer patients and survivors.  Oncology (Williston Park). 2007 Nov;21(12):1462-72; discussion 1473, 1476, 1481 passim.

Alley E, et al. Cutaneous toxicities of cancer therapy. Curr Opin Oncol. 2002 Mar;14(2):212-6.

Boone SL, et al. Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results. Oncology. 2007;72(3-4):152-9. Epub 2007 Dec 21.

Fox LP. Nail toxicity associated with epidermal growth factor receptor inhibitor therapy. J Am Acad Dermatol. 2007 Mar;56(3):460-5. Epub 2006 Dec 4.

Fox LP. Pathology and management of dermatologic toxicities associated with anti-EGFR therapy. Oncology (Williston Park). 2006 Apr;20(5 Suppl 2):26-34.

Hammond-Thelin LA. Cutaneous reactions related to systemic immunomodulators and targeted therapeutics. Dermatol Clin. 2008 Jan;26(1):121-59, ix.

 Heidary N, et al. Chemotherapeutic agents and the skin: An update. J Am Acad Dermatol. 2008 Apr;58(4):545-70.  

Hu JC, et al. Cutaneous side effects of epidermal growth factor receptor inhibitors: clinical presentation, pathogenesis, and management. J Am Acad Dermatol. 2007 Feb;56(2):317-26. Epub 2006 Dec 1.  

Lacouture ME, et al. Clinical management of EGFRI dermatologic toxicities: US perspective. Oncology (Williston Park). 2007 Oct;21(11 Suppl 5):17-21. [THIS ENTIRE SUPPLEMENT IS RELEVANT]

Lacouture ME, et al. Non-rash skin toxicities associated with novel targeted therapies. Clin Lung Cancer. 2006 Dec;8 Suppl 1:S36-42.

Lynch, TJ Jr, et al. Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management. Oncologist. 2007 May;12(5):610-21.

Robert C, et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol. 2005 Jul;6(7):491-500.

Sanborn RE, Sauer DA. Cutaneous reactions to chemotherapy: commonly seen, less described, little understood. Dermatol Clin. 2008 Jan;26(1):103-19, ix.  

Wyatt AJ, et al. Cutaneous reactions to chemotherapy and their management. Am J Clin Dermatol. 2006;7(1):45-63.